Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Busch

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2012
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaChristoph Seidel, Jonas Busch, Steffen Weikert, et al.
Therapeutics and Clinical Risk Management|December 31, 2020
Early Continence and Extravasation After Open Retropubic Radical Prostatectomy - Interrupted vs Continuous Suturing for Vesicourethral AnastomosisNora Köhler, Nasrin El-Bandar, Andreas Maxeiner, et al.
International Journal of Molecular Sciences|March 2, 2017
Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical ProstatectomyFrank Friedersdorff, Britt Groß, Andreas Maxeiner, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Urolithiasis in Renal Allografts: Complications and OutcomesFrank Friedersdorff, Nasrin El-Bandar, Jonas Busch, et al.
Translational Andrology and Urology|July 18, 2020
Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysisCharis Kalogirou, Jörg Ellinger, Glen Kristiansen, et al.
The Lancet. Infectious Diseases|July 15, 2022
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trialMaciej Jacewicz, Karsten Günzel, Erik Rud, et al.
Urologia Internationalis|March 9, 2012
Selective lymph node dissection for castration-resistant prostate cancerJonas Busch, Stefan Hinz, Carsten Kempkensteffen, et al.
Advances in Therapy|January 6, 2017
The Effect of Evolving Strategies in the Surgical Management of Organ-Confined Prostate Cancer: Comparison of Data from 2005 to 2014 in a Multicenter SettingMargit Pohle, Ahmed Magheli, Tom Fischer, et al.
Oncotarget|November 8, 2017
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patientsAndreas Maxeiner, Ergin Kilic, Julia Matalon, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Urology|March 16, 2016
Serum Vitamin D is Not Helpful for Predicting Prostate Cancer Aggressiveness Compared with the Prostate Health IndexCarsten Stephan, Michael Lein, Julia Matalon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2012
Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinomaChristoph Seidel, Jonas Busch, Steffen Weikert, et al.
Therapeutics and Clinical Risk Management|December 31, 2020
Early Continence and Extravasation After Open Retropubic Radical Prostatectomy - Interrupted vs Continuous Suturing for Vesicourethral AnastomosisNora Köhler, Nasrin El-Bandar, Andreas Maxeiner, et al.
International Journal of Molecular Sciences|March 2, 2017
Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical ProstatectomyFrank Friedersdorff, Britt Groß, Andreas Maxeiner, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Urolithiasis in Renal Allografts: Complications and OutcomesFrank Friedersdorff, Nasrin El-Bandar, Jonas Busch, et al.
Translational Andrology and Urology|July 18, 2020
Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysisCharis Kalogirou, Jörg Ellinger, Glen Kristiansen, et al.
The Lancet. Infectious Diseases|July 15, 2022
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trialMaciej Jacewicz, Karsten Günzel, Erik Rud, et al.
Urologia Internationalis|March 9, 2012
Selective lymph node dissection for castration-resistant prostate cancerJonas Busch, Stefan Hinz, Carsten Kempkensteffen, et al.
Advances in Therapy|January 6, 2017
The Effect of Evolving Strategies in the Surgical Management of Organ-Confined Prostate Cancer: Comparison of Data from 2005 to 2014 in a Multicenter SettingMargit Pohle, Ahmed Magheli, Tom Fischer, et al.
Oncotarget|November 8, 2017
The prostate health index PHI predicts oncological outcome and biochemical recurrence after radical prostatectomy - analysis in 437 patientsAndreas Maxeiner, Ergin Kilic, Julia Matalon, et al.
Pageof 9